Boston Scientific Corp
NYSE:BSX
Boston Scientific Corp
NYSE:BSX
Price:
72.55 USD
-0.41%
Market Closed
Updated:
May 7, 2024
Boston Scientific Corp
Operating Income
|
Boston Scientific Corp
Operating Income Peer Comparison
Comparables:
BDX
SYK
ABT
ISRG
DXCM
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Income
$2.5B
|
CAGR 3-Years
46%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Income
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
5%
|
|
|
Stryker Corp
NYSE:SYK
|
Operating Income
$4.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Income
$6.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Income
$1.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
|
Dexcom Inc
NASDAQ:DXCM
|
Operating Income
$651.6m
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Boston Scientific Corp's Operating Income?
Operating Income
2.5B
USD
2.5B
USD
Based on the financial report for Mar 31, 2024, Boston Scientific Corp's Operating Income amounts to 2.5B USD.
What is Boston Scientific Corp's Operating Income growth rate?
Operating Income CAGR 10Y
10%
10%
Over the last year, the Operating Income growth was 16%. The average annual Operating Income growth rates for Boston Scientific Corp have been 46% over the past three years , 7% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
